« Previous
Next »
Nuclear Medicine and Biology
Volume 33, Issue 2
, Pages
217-226
, February 2006
Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides
To access this article, please choose from the options below
PII: S0969-8051(05)00276-3
doi: 10.1016/j.nucmedbio.2005.11.001
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Nuclear Medicine and Biology
Volume 33, Issue 2
, Pages
217-226
, February 2006
